Sonoma Pharmaceuticals Price Chart
Sonoma Pharmaceuticals Volume Chart
Sonoma Pharmaceuticals Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
-0.05(-2.00%)
| Open | $2.51 |
|---|---|
| Close | $2.46 |
| Low | $2.43 |
| Low Change | -0.07 (-2.99%) |
| High | $2.51 |
| High Change | +0.00 (+0.00%) |
| Range | $0.07 |
| Volume | 2.044K |
| Dollar Volume | $5.02K |
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.07(+2.93%)
| Open | $2.39 |
|---|---|
| Close | $2.46 |
| Low | $2.39 |
| Low Change | 0.00 (0.00%) |
| High | $2.50 |
| High Change | +0.11 (+4.39%) |
| Range | $0.11 |
| Volume | 9.096K |
| Dollar Volume | $22.38K |
Premarket Yesterday
*No Trades in Segment
Sonoma Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $2.47 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.63 |
| 20 Day Moving Average (SMA20) | $2.74 |
| 50 Day Moving Average (SMA50) | $3.12 |
| 100 Day Moving Average (SMA100) | $3.37 |
| 200 Day Moving Average (SMA200) | $3.56 |
Sonoma Pharmaceuticals Statistics
| Average Volume (30 Days) | 16.08K |
|---|---|
| P/E Ratio (Current) | -1.22 |
| EPS (Current) | -$1.95 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$3.72M |
| Cash Ratio | 0.61 |
| Current Ratio | 2.88 |
| Quick Ratio | 2.00 |
| Debt to Equity | 0.00 |
| Enterprise Value | $1.56M |
| EV to EBITDA | -0.59 |
| EV to Sales | 0.09 |
| Price to Book | 1.20 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 0.23 |
| Return on Assets | -0.25% |
| Return on Equity | -0.98% |
Sonoma Pharmaceuticals Stock Splits
There have been 4 stock splits for Sonoma Pharmaceuticals (SNOA). The last reverse stock split occured on August 30, 2024 and reduced the outstanding shares at a ratio of 20:1.
| Date | Type | Ratio |
|---|---|---|
| Aug 30, 2024 | Reverse | 20:1 |
| Jun 20, 2019 | Reverse | 9:1 |
| Jun 27, 2016 | Reverse | 5:1 |
| Apr 1, 2013 | Reverse | 7:1 |
Sonoma Pharmaceuticals Dividends
There have been no dividends for Sonoma Pharmaceuticals (SNOA).